By Amina Kafil The European Commission, in a recent announcement, has given the green light for an enhanced COVID-19 vaccine from Pfizer (PFE.N) and its German collaborator BioNTech (22UAy.DE) to be integrated into the upcoming autumn vaccination campaigns across European Union (EU) countries. This move aims to tackle the prevalent Omicron XBB.1.5 variant effectively. The … Continue reading EU’s Pfizer Pivot: A Wise Move?